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Introduction 
THE PROBLEM 
• Burn injuries are common and always lead to 
scarring. Deep burns and those taking longer to heal 
often heal pathologically.  
• Scarring, especially pathological hypertrophic 
scarring, leads to morbid symptoms (pain, pruritus), 
functional impairment, and negative aesthetic and 
psychiatric consequences.  
• Traditional treatment is excision and skin grafting, a 
large operation with donor site morbidity and is 
problematic in complex anatomical areas (face, hands). 
Other treatment modalities (lasers, silicone, steroids) 
have side effects, low effectiveness, or lack of 
supporting evidence.   
 
A POTENTIAL SOLUTION 
• Autologous adipose tissue grafting (“Fat Grafting”) and 
adipose-derived stem cell (ADSC) therapy may 
improve wound healing and scar outcomes in acute 
burn, excisional, and radiation skin injury models. 
• Clinical case reports suggest adipose therapeutics may 
improve the remodeling of chronically scarred skin 
tissue by improving skin color, texture, pliability, and 
patient symptoms. At least one clinical trial is ongoing.  
• Most basic research focuses on acute phase 
intervention, few if any studies examine adipose derived 
therapeutics for improved remodeling of chronic scars.  
 
PROJECT GOALS 
• Determine if adipose tissue can improve scar 
remodeling subacutely after acute wound healing 
phases have concluded in a mouse model of 
thermal injury. 
• Compare the effects of processed lipoaspirate to 
adipose-derived stem cells.  
• N = 50 CD1 Nu/Nu (Athymic, nude) mice received standardized 70°C 10s burn (under anesthesia and analgesia) 
with a brass rod to dorsal skin and monitored for six weeks while chronic scars formed (Fig 1-3). 
• At six weeks animals were randomized to five groups (Table 1); non-injected controls received no injection, other 
groups received subcutaneous injection of 0.6mL human lipoaspirate, human ADSCs in matrigel hydrogel 
suspension, or matrigel control. Adipose tissue from discarded human pannus. ADSCs from SVF ex-vivo culture. 
• Skin perfusion measured with Hyperspectral Imaging (HSI) and digital photos were taken at 4 time points.  
• Mice were sacrificed at 10 weeks post-burn (PB) (4 weeks after engraftment) for skin histology.  
• Scar wound area and oxy and deoxy hemoglobin (HSI measures) were determined at all time points. 
• Skin tissue samples were stained for vascularity (CD31) and collagen composition (Picro-Sirius red, Masson’s 
Trichrome). Matrigel explants were H&E stained.  
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Future Directions 
Table 1 Group 1 Group 2 Group 3 Group 4 Group 5 
Treatment Non-
injected 
Control 
Matrigel 
Control 
Human high 
density 
Lipoaspirate 
Low Dose 
(104) ADSCs 
in Matrigel 
High Dose 
(106) ADSCs 
in Matrigel 
Sample N=10 N=10 N=10 N=10 N=10 
Figure 2. Scar micro and macroscopic progression from pilot study. Fig 3 (below) 
shows scar area progression through 6 weeks post-burn due to scar contraction. 
Goel A, Shrivastava P. Post-burn scars and scar contractures. Indian J Plast Surg. 2010 
Sep;43(Suppl):S63-71.  
 
MARIANO E, ILFELD B, CHENG G, NICODEMUS H, SANTHANAM SURESH Feasibility 
of ultrasound-guided peripheral nerve block catheters for pain control on pediatric medical 
missions in developing countries. Paediatr Anaesth. 2008 July; 18(7): 598–601.  
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Figure 1. Project timeline 
and outcomes. 
Examples of burn scarring. Hypertrophic scar areas 
are raised and erythematous. Note also changes in 
texture, pigmentation, and contraction of skin limiting 
mobility.   
• Scar wound area: Lipoaspirate treated mice had significantly reduced perceived scar area compared to controls at 10 weeks (Fig 4).  
• Histology: CD31 IHC trouble. Dermal vessels visualized on Masson’s Trichrome counted in 3 hpfs/slide show increase in G3 compared to 
G1 (Fig 5). Collagen picro photomorphometry ongoing. H&E stain of matrigel explants show living cells within hydrogel matrix. 
• Hyperspectral imaging: Changes in oxy, deoxy, and total hemoglobin (Hb) consistent all mice until week 6 prior to treatment (not shown). 
G3 significantly increased oxy Hb from week 6 to 10 compared to other groups (Fig 6). G3-5 significantly lower deoxy Hb compared G1 
10:6 wks (~0.9, not shown). Total Hb reduced (~0.9) in G4-5 compared to G1 at 10:6 wks (not shown).  
• ADSC FACS analysis: CD34-, CD45-, CD24-, CD144-, CD90+, CD44+, CD29+. CD73 and CD105 mostly – (Fits MSC phenotype.) 
• Lipoaspirate may improve scar remodeling, possibly 
mediated by increased blood vessel density 
improving oxygenation, resulting in smaller 
perceived scar area.  
• Lipoaspirate may retain a native scaffold allowing 
improved cell survival and angiogenesis preferentially 
to de novo vasculogenesis from direct ADSC 
differentiation.  
• ADSCs, although promising in other studies, did not 
improve scar area, perfusion, or BV density in this 
model. Matrigel may have contributed to this finding as 
growth factor penetration to healing site may be limited. 
• Limitations: Variability in mouse skin phenotype may 
have contributed error. Burn models are difficult to 
standardize: burn injury may not have been equal 
across all mice. Time and resources limited extent of 
analysis. 
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• Molecular analysis of scar remodeling targets such 
as TGF-β1/3, α-SMA, col1,3, VEGF, MMP9, SMAD-3. 
• Experiment with other hydrogels or no hydrogel in 
case this was a factor in reducing ADSC efficacy. 
• Continue attempts at improving photomorphometric 
analysis of picrosirus red collagen staining.  
• Include a “supercharged” lipoaspirate group for 
comparison (Lipo + ADSCs). 
• Consider porcine studies, a higher fidelity human skin 
model and better model of hypertrophic scarring. 
• Consider consultation with dermatopathology experts 
for new clues for histological analysis. 
* p < 0.05 vs. group 1, ** p < 0.01 vs. group 1, + p <0.05 vs. group 2, ++ p < 0.01 vs. group 2 
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